tetano
Editor, Senior Moderator
Circ J
. 2022 Jan 29.
doi: 10.1253/circj.CJ-21-0687. Online ahead of print.
Cardiovascular Complications of Hospitalized Patients With Coronavirus Disease 2019 in a Japanese Registry in 2020
Yukio Hiroi[SUP] 1 [/SUP], Hiroshi Ohtsu[SUP] 2 [/SUP], Yukari Uemura[SUP] 2 [/SUP], Kayoko Hayakawa[SUP] 3 [/SUP], Yusuke Asai[SUP] 4 [/SUP], Satoshi Kutsuna[SUP] 3 5 [/SUP], Mari Terada[SUP] 2 3 [/SUP], Wataru Sugiura[SUP] 2 [/SUP], Norio Ohmagari[SUP] 3 [/SUP]
Affiliations
Abstract
Background: Cardiovascular complications of coronavirus disease 2019 (COVID-19) are critical for prognosis but have not been elucidated in Japan.Methods and Results:The COVID-19 Registry Japan, which included data from 19,853 individuals at the end of 2020, was analyzed. The incidences of cardiovascular complications were 0.098% for myocarditis/pericarditis/cardiomyopathy, 0.48% for ventricular tachycardia/fibrillation, 0.17% for myocardial ischemia, 0.062% for endocarditis, 0.59% for deep vein thrombosis, 0.19% for pulmonary embolism, and 0.37% for cerebral infarction/hemorrhage. Excluding endocarditis, all complications were associated with increased in-hospital mortality.
Conclusions: Cardiovascular complications of COVID-19 were infrequent in Japan but were associated with poor prognosis.
Keywords: Cardiovascular complications; Coronavirus disease 2019 (COVID-19); National registry.
. 2022 Jan 29.
doi: 10.1253/circj.CJ-21-0687. Online ahead of print.
Cardiovascular Complications of Hospitalized Patients With Coronavirus Disease 2019 in a Japanese Registry in 2020
Yukio Hiroi[SUP] 1 [/SUP], Hiroshi Ohtsu[SUP] 2 [/SUP], Yukari Uemura[SUP] 2 [/SUP], Kayoko Hayakawa[SUP] 3 [/SUP], Yusuke Asai[SUP] 4 [/SUP], Satoshi Kutsuna[SUP] 3 5 [/SUP], Mari Terada[SUP] 2 3 [/SUP], Wataru Sugiura[SUP] 2 [/SUP], Norio Ohmagari[SUP] 3 [/SUP]
Affiliations
- PMID: 35095056
- DOI: 10.1253/circj.CJ-21-0687
Abstract
Background: Cardiovascular complications of coronavirus disease 2019 (COVID-19) are critical for prognosis but have not been elucidated in Japan.Methods and Results:The COVID-19 Registry Japan, which included data from 19,853 individuals at the end of 2020, was analyzed. The incidences of cardiovascular complications were 0.098% for myocarditis/pericarditis/cardiomyopathy, 0.48% for ventricular tachycardia/fibrillation, 0.17% for myocardial ischemia, 0.062% for endocarditis, 0.59% for deep vein thrombosis, 0.19% for pulmonary embolism, and 0.37% for cerebral infarction/hemorrhage. Excluding endocarditis, all complications were associated with increased in-hospital mortality.
Conclusions: Cardiovascular complications of COVID-19 were infrequent in Japan but were associated with poor prognosis.
Keywords: Cardiovascular complications; Coronavirus disease 2019 (COVID-19); National registry.